GGrantIndex
← Leaderboards

Daniel M Spielman

Stanford University

$15,911,360
Attributed
$19,114,686
Total exposure
17
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.4M · FY200725
$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$19,114,686 · 17

By mechanism

R01$16,053,262 · 10
S10$2,000,000 · 1
P41$632,040 · 5
R21$429,384 · 1

Top collaborators

Most similar at Stanford University

Same institution · by research overlap

Others in their field

Top investigators on “Measurement

Research focus

MeasurementMagnetic Resonance ImagingIn VivoGlucoseTissuesMagnetic Resonance SpectroscopySignal TransductionBrainMetabolicImageInsightMetabolismPyruvateMalignant NeoplasmsResponseResolutionDetectionMagnetic Resonance Spectroscopic ImagingEnergy MetabolismLabelAlanineBaseNoiseRattus

Grant awards (48)

Enhanced Deuterium Metabolic Imaging (DMI) of Metabolic Reprogramming in Brain Tumors$629,558
R01 · FY2025 · CA · contact PI
Neurometabolic Outcomes of Different Cardiopulmonary Bypass Strategies$676,868
R01 · FY2024 · HL
Enhanced Deuterium Metabolic Imaging (DMI) of Metabolic Reprogramming in Brain Tumors$579,483
R01 · FY2024 · CA · contact PI
Neurometabolic Outcomes of Different Cardiopulmonary Bypass Strategies$730,627
R01 · FY2023 · HL
Enhanced Deuterium Metabolic Imaging (DMI) of Metabolic Reprogramming in Brain Tumors$610,360
R01 · FY2023 · CA · contact PI
Neurometabolic Outcomes of Different Cardiopulmonary Bypass Strategies$714,427
R01 · FY2022 · HL
Imaging Biomarkers for Glioma Treatment Response$216,751
R01 · FY2022 · CA · contact PI
Neurometabolic Outcomes of Different Cardiopulmonary Bypass Strategies$789,481
R01 · FY2021 · HL
Imaging Biomarkers for Glioma Treatment Response$221,174
R01 · FY2021 · CA · contact PI
Robust 1H MRSI of GABA, Glutamate, Glutamine, and Glutathione$420,179
R01 · FY2020 · MH · contact PI
Imaging Biomarkers for Glioma Treatment Response$275,857
R01 · FY2020 · CA · contact PI
Robust 1H MRSI of GABA, Glutamate, Glutamine, and Glutathione$381,249
R01 · FY2019 · MH · contact PI
Metabolic Therapy of GBM guided by MRS of hyperpolarized 13C-pyruvate$556,142
R01 · FY2018 · CA
Imaging Brain Metabolism Using MRS of Hyperpolarized 13C-Pyruvate$501,869
R01 · FY2018 · EB · contact PI
Robust 1H MRSI of GABA, Glutamate, Glutamine, and Glutathione$334,606
R01 · FY2018 · MH · contact PI
Metabolic Therapy of GBM guided by MRS of hyperpolarized 13C-pyruvate$548,510
R01 · FY2017 · CA
Imaging Brain Metabolism Using MRS of Hyperpolarized 13C-Pyruvate$504,002
R01 · FY2017 · EB · contact PI
Robust 1H MRSI of GABA, Glutamate, Glutamine, and Glutathione$359,954
R01 · FY2017 · MH · contact PI
Metabolic Therapy of GBM guided by MRS of hyperpolarized 13C-pyruvate$553,640
R01 · FY2016 · CA
Imaging Brain Metabolism Using MRS of Hyperpolarized 13C-Pyruvate$489,075
R01 · FY2016 · EB · contact PI
Novel MRS methods for measuring brain energetics and neurotransmitter cycling$200,734
R21 · FY2016 · EB · contact PI
Metabolic Therapy of GBM guided by MRS of hyperpolarized 13C-pyruvate$548,148
R01 · FY2015 · CA
Imaging Brain Metabolism Using MRS of Hyperpolarized 13C-Pyruvate$505,390
R01 · FY2015 · EB · contact PI
Novel MRS methods for measuring brain energetics and neurotransmitter cycling$228,650
R21 · FY2015 · EB · contact PI
Metabolic Therapy of GBM guided by MRS of hyperpolarized 13C-pyruvate$575,027
R01 · FY2014 · CA
Hyperpolarizer for 13C MR Metabolic Imaging of Human Subjects and Animal Models$2,000,000
S10 · FY2013 · OD · contact PI
Metabolic Imaging of the Cardioprotective Effects of Alcohol and ALDH2 Activators$444,651
R01 · FY2013 · AA · contact PI
Metabolic Imaging of the Cardioprotective Effects of Alcohol and ALDH2 Activators$478,120
R01 · FY2012 · AA · contact PI
Metabolic Imaging of the Cardioprotective Effects of Alcohol and ALDH2 Activators$473,237
R01 · FY2011 · AA · contact PI
1H MRSI of the Human Brain at 7T$211,167
R01 · FY2011 · MH · contact PI
Metabolic Imaging of the Cardioprotective Effects of Alcohol and ALDH2 Activators$480,133
R01 · FY2010 · AA · contact PI
1H MRSI of the Human Brain at 7T$313,832
R01 · FY2010 · MH · contact PI
MEASUREMENT OF ETHANOL METABOLISM IN RAT LIVER USING MRS OF [1-13C]PYRUVATE$30,834
P41 · FY2010 · RR · contact PI
1H MRSI of the Human Brain at 7T$313,832
R01 · FY2009 · MH · contact PI
MEASUREMENT OF ETHANOL METABOLISM IN RAT LIVER USING MRS OF [1-13C]PYRUVATE$30,076
P41 · FY2009 · RR · contact PI
1H MRSI of the Human Brain at 7T$326,882
R01 · FY2008 · MH · contact PI
SPECTRAL-SPATIAL PULSES FOR REDUCED DISPLACEMENT ARTIFACTS AT 7 TESLA$57,560
P41 · FY2007 · RR · contact PI
MR SPECTROSCOPIC IMAGING IN ALZHEIMER'S DISEASE$311,291
R01 · FY2003 · AG
MAGNETIC RESONANCE SPECTROSCOPIC NEOPLASM IMAGING$255,730
R01 · FY2003 · CA
MAGNETIC RESONANCE SPECTROSCOPIC NEOPLASM IMAGING$244,120
R01 · FY2002 · CA
DYNAMIC MAGNETIC RESONANCE IMAGING OF PEDIATRIC KIDNEY$120,630
P41 · FY2002 · RR
ANALYSIS OF IMPROVED HOMOGENEITY USING HIGHER ORDER SHINS FOR CSI OF BRAIN$120,630
P41 · FY2002 · RR
MAGNETIC RESONANCE SPECTROSCOPIC NEOPLASM IMAGING$245,685
R01 · FY2001 · CA
DYNAMIC MAGNETIC RESONANCE IMAGING OF PEDIATRIC KIDNEY$120,630
P41 · FY2001 · RR
ANALYSIS OF IMPROVED HOMOGENEITY USING HIGHER ORDER SHINS FOR CSI OF BRAIN$120,630
P41 · FY2001 · RR
MAGNETIC RESONANCE SPECTROSCOPIC NEOPLASM IMAGING$232,205
R01 · FY2000 · CA
ANALYSIS OF IMPROVED HOMOGENEITY USING HIGHER ORDER SHINS FOR CSI OF BRAIN$15,525
P41 · FY2000 · RR
DYNAMIC MAGNETIC RESONANCE IMAGING OF PEDIATRIC KIDNEY$15,525
P41 · FY2000 · RR